Abstract:Background: Astilbin is a flavonoid phytoconstituent extracted from Chinese herb Rhizoma Smilacis Glabrae, a common Chinese food ingredient. Objectives: The present study used astilbin as a model drug to develop food-based nanoemulsified formulations. These formulations were then tested for their possible role in countering Oxaliplatin (OXP) associated oxidative stress. Materials and Methods: Thirty six healthy male BALB/c mice of age 10–12 weeks and weight 25–30 g were included in the present study. The mice were administered OXP through intraperitoneal route in a dose of 8 mg/kg for a period of 4 days. The animals in the control group were administered a 10 ml/kg dose of 5% (w/v) glucose solution. For evaluating the hepatoprotective effect of developed formulations on OXP-induced liver injury, the animals from treatment groups were administered once daily dose of drug loaded formulations 60 min before OXP treatments (200 mg/kg equivalent of formulation, intraperitoneally) for 4 days. Finally, the blood and hepatic tissue samples were obtained for future analysis. Results: We successfully developed non-toxic nanoemulsion systems for astilbin, which comprised of different non-toxic food ingredients of astilbin and evaluated the potential reversing the OXP induced liver injury. The food-based nanoemulsions possessed attractive physical properties and exhibited sufficient stability profile when subjected to freeze-thaw cycles as well as 6-month storage at ambient and cold temperatures. Furthermore, excellent cumulative in vitro drug permeation was reported for the prepared formulations through dialysis membrane bags. We also observed the significant reduction in biomarkers of hepatic oxidative stress, caused by OXP chemotherapy in experimental mice, thereby indicating a marked reversal of liver injury. Conclusion: We concluded that nanoemulsified astilbin can be used as therapeutic agent to counter OXP-associated oxidative stress.

Orally dual-targeted astaxanthin nanoparticles as the novel dietary supplement for alleviating hepatocyte oxidative stress

Design and Preparation of Multifunctional Astaxanthin Nanoparticles with Good Acid Stability and Hepatocyte-Targeting Ability for Alcoholic Liver Injury Alleviation

Hepatic-targeted Delivery of Astaxanthin for Enhanced Scavenging Free Radical Scavenge and Preventing Mitochondrial Depolarization.

Hepatic parenchymal cell and mitochondrial-targeted astaxanthin nanocarriers for relief of high fat diet-induced nonalcoholic fatty liver disease

Co-encapsulated astaxanthin and kaempferol nanoparticles: fabrication, characterization, and their potential synergistic effects on treating non-alcoholic fatty liver disease

A bifunctional hepatocyte-mitochondrion targeting nanosystem for effective astaxanthin delivery to the liver

Prevention of Hypercholesterolemia with "Liposomes in Microspheres" Composite Carriers: A Promising Approach for Intestinal-Targeted Oral Delivery of Astaxanthin

Preparation of astaxanthin-loaded composite micelles with coaxial electrospray technology for enhanced oral bioavailability and improved antioxidation capability

Astaxanthin From Haematococcus pluvialis Prevents High-Fat Diet-Induced Hepatic Steatosis and Oxidative Stress in Mice by Gut-Liver Axis Modulating Properties

Design of Astaxanthin-Loaded Core-Shell Nanoparticles Consisting of Chitosan Oligosaccharides and Poly(lactic- co-glycolic acid): Enhancement of Water Solubility, Stability, and Bioavailability.

Preparation of cellulose-based nanoparticles via electrostatic self-assembly for the pH-responsive delivery of astaxanthin

Astaxanthin nanoparticles ameliorate dextran sulfate sodium-induced colitis by alleviating oxidative stress, regulating intestinal flora, and protecting the intestinal barrier

Engineering Milk-Derived Exosome for Enhancing Cellular Astaxanthin Delivery

Enhancing the oral bioavailability of natural astaxanthin using plant-based micro- and nano-encapsulation materials: Results of an In vitro evaluation and a cross-over study in humans

Bi-functional astaxanthin macromolecular nanocarriers to alleviate dextran sodium sulfate-induced inflammatory bowel disease

A New Tailored Nanodroplet Carrier of Astaxanthin Can Improve Its Pharmacokinetic Profile and Antioxidant and Anti-Inflammatory Efficacies

Microfluidic fabrication of size-controlled nanocarriers with improved stability and biocompatibility for astaxanthin delivery

Chitosan-graft-poly(lactide) nanocarriers: An efficient antioxidant delivery system for combating oxidative stress

Preparation of a nanoemulsified drug delivery system of astilbin using edible formulation components: In vivo evaluation of oxaliplatin-induced cirrhotic liver injury

Astaxanthin biosynthesis for functional food development and space missions

Lipid-Lowering and Antioxidant Effects of Self-Assembled Astaxanthin-Anthocyanin Nanoparticles on High-Fat Caenorhabditis elegans